March 2, 2026 · Form 4 insider transaction
Leonard Keith R bought 27,052 shares of Arcutis Biotherapeutics, Inc. at $8.63 per share, a transaction worth $233.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on November 18, 2025, by the Reporting Person, with a plan end date of February 16, 2027.